If an eligible patient dies while being treated with an individualized investigational drug, biological product, or device, the eligible patient's heirs are not liable for any outstanding debt related to the treatment, including any costs attributed to lack of insurance coverage for the treatment.
N.C. Gen. Stat. § 90-325.32
No liability to heirs for outstanding debt related to use of individualized investigational drugs, biological products, or devices
Known as the Right to Try Act
The act spans §§ 90–90 (37 sections).
2024-36, s. 1.
Official source: North Carolina General Assembly. Reproduced from public-domain North Carolina statutes; confirm against the official source for the current text. Not legal advice.